Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-21

Clinical Trial Update: High Altitude (HA) Residents With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Artery Pressure (PAP) Assessed at HA (3200 m) vs LA (760 m) [NA]

View source ↗

Summary

A completed clinical trial from the University of Zurich evaluated pulmonary artery pressure in high-altitude residents with high altitude pulmonary hypertensio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Zurich | Conditions: High Altitude Pulmonary Hypertension | NA | Status: COMPLETED